SHIRAZ BREAST CANCER STUDY PART II: SCREENING MAMMOGRAPHY IN A OPULATIONBASED BREAST CANCER SURVEY
نویسندگان
چکیده مقاله:
The purpose of this study was to assess the detection rate of mammography in breast cancer and the attendance rate in response to the call for screening mammography in females before the development of symptoms. One-thousand four-hundred and thirty-eight women over 35 years of age who had no complaint and had normal breast examinations were called for mammography. Out of the 10,000 women under study for breast cancer, 1,438 women were randomly called for mammography and actually 985 subjects turned up for mammography. All the mammograms were reported by the same radiologist, and physical examination of the breast was carefully performed by both radiologist and surgeon on any patient suspected of having a lesion in mammography. A total of 4 malignant nonpalpable lesions were detected in 985 screening mammograms. The prevalence of breast malignancy is lower in our female population compared with the west and our detection rate in subjects with no physical findings comprises 0.4%. Since only 985 women turned up for screening mammography, the attendance rate is calculated as 68.5%. Mammographic findings consisted of 96 cases of benignappearing breast nodules, 194 cases of calcification, 25 intra-mammary lymph nodes, 189 enlarged axillary nodes and 83 dense breasts. In conclusion, although mammography is a very helpful procedure in screening for breast cancer, the response can be low for a call for mammography and the prevalence of malignancy of the breast has been underestimated in the past.
منابع مشابه
shiraz breast cancer study part ii: screening mammography in a opulationbased breast cancer survey
the purpose of this study was to assess the detection rate of mammography in breast cancer and the attendance rate in response to the call for screening mammography in females before the development of symptoms. one-thousand four-hundred and thirty-eight women over 35 years of age who had no complaint and had normal breast examinations were called for mammography. out of the 10,000 women under ...
متن کاملBreast Cancer and Screening
سرطان پستان یکی از شایع ترین بیماریهای بدخیم و اولین علت مرگ و میر زنان بوده و تقریبا یک سوم تمام سرطانهای زنان را تشکیل می دهد.
متن کاملMammography and breast cancer screening.
Dr. Pan and colleagues in this issue commented that there is a substantial policy favoring and emphasis on early detection and treatment of various kinds of cancers prevalent in developed countries. In Taiwan, the government not only provides Pap smears for cervical cancer screening, but has maintained a nationwide, free and biennial mammographic screening program since 2004. There was a signif...
متن کاملindividualized breast cancer screening versus population-based mammography screening programs
na
متن کاملBreast cancer screening: Does tomosynthesis augment mammography?
Digital breast tomosynthesis (DBT) is a relatively new imaging technology that is being adopted widely for breast cancer screening. Initial evidence suggests that it may reduce recall rates and increase cancer detection rates when added to digital mammography screening. However, more rigorous, prospective studies are needed to determine whether it improves long-term clinical outcomes of breast ...
متن کاملScreening for breast cancer with mammography.
BACKGROUND A variety of estimates of the benefits and harms of mammographic screening for breast cancer have been published and national policies vary. OBJECTIVES To assess the effect of screening for breast cancer with mammography on mortality and morbidity. SEARCH STRATEGY We searched PubMed (June 2005). SELECTION CRITERIA Randomised trials comparing mammographic screening with no mammo...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ذخیره در منابع من قبلا به منابع من ذحیره شده{@ msg_add @}
عنوان ژورنال
دوره 13 شماره 2
صفحات 97- 100
تاریخ انتشار 1999-08
با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023